408 related articles for article (PubMed ID: 6417375)
1. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
Kikuchi K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
[TBL] [Abstract][Full Text] [Related]
3. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
4. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
7. Antigens on human plasma cells identified by monoclonal antibodies.
Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
[TBL] [Abstract][Full Text] [Related]
8. Studies on the distribution of the antigens detected by some newly prepared monoclonal antibodies in normal hemopoietic and leukemic cells.
Babusíková O; Ujházy P; Hrivnáková A; Chorváth B; Poláková K
Neoplasma; 1985; 32(6):657-62. PubMed ID: 4088385
[TBL] [Abstract][Full Text] [Related]
9. A unique antigen on mature B cells defined by a monoclonal antibody.
Link MP; Bindl J; Meeker TC; Carswell C; Doss CA; Warnke RA; Levy R
J Immunol; 1986 Nov; 137(9):3013-8. PubMed ID: 3489782
[TBL] [Abstract][Full Text] [Related]
10. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
11. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
12. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
14. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Tazzari PL; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S
Clin Exp Immunol; 1987 Oct; 70(1):192-200. PubMed ID: 3319299
[TBL] [Abstract][Full Text] [Related]
15. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
16. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
[TBL] [Abstract][Full Text] [Related]
17. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens.
Pinchouk VG; Sidorenko SP; Gluzman DF; Vetrova EP; Berdova AG; Schlapatskaya LN
Anticancer Res; 1988; 8(6):1377-80. PubMed ID: 3265315
[TBL] [Abstract][Full Text] [Related]
19. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
20. Surface antigens defined by monoclonal antibodies as tumor markers in human leukemia.
Knapp W; Majdic O; Bettelheim P; Liszka K; Lutz D
Cancer Detect Prev; 1983; 6(1-2):281-6. PubMed ID: 6883386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
